Progression free survival as a surrogate endpoint for overall survival in first-line therapy of advanced ovarian cancer : A Gynecologic Cancer InterGroup (GCIG) individual patient-level meta-analysis
2018
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI